研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2026 年的期刊文章 · 第 8 页
共 1756 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2026-09-08 到 2026-08-27。
按期刊、按主题看 →
JASA Bayesian Methods · 发表于 2026-09-08,收录于 2026-07-24
Not available
摘要
Stochastic process models for spatiotemporal data underlying random fields find substantial utility in a range of scientific disciplines. Subsequent to predictive inference on the values of the random field (or spatial surface indexed continuously over time) at arbitrary space-time coordinates, scientific interest often turns to gleaning information regarding zones of rapid spatial-temporal change. We develop Bayesian modeling and inference for directional rates of change along a given surface. These surfaces, which demarcate regions of rapid change, are referred to as "wombling" surface boundaries. Existing methods for studying such changes have often been associated with curves and are not easily extendable to surfaces resulting from curves evolving over time. Our current contribution devises a fully model-based inferential framework for analyzing differential behavior in spatiotemporal responses by formalizing the notion of a "wombling" surface boundary using conventional multi-linear vector analytic frameworks and geometry followed by posterior predictive computations using triangulated surface approximations. We illustrate our methodology with comprehensive simulation experiments followed by multiple applications in neuroimaging; environmental and climate science and pollutant analysis in environmental health. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via PubMed)*
SiM Diagnostics & Prediction Clinical Trials · 发表于 2026-09-08
Libby Daniells, Julia Geronimi, Hugo Hadjur, Sandrine Guilleminot, Pavel Mozgunov
摘要
Biomarker identification plays a crucial role in precision medicine, where treatments are tailored to patients' intrinsic factors. Predictive biomarkers can be used to identify patients who are more likely to benefit from a treatment. However, identifying and validating such biomarkers pose substantial statistical and practical challenges, especially in the small sample setting. Several methods have been proposed for assessing whether a biomarker has a predictive effect, including the Average Kolmogorov‐Smirnov Approach (AKSA), which has been shown to have improved operating characteristics for inference compared to alternative approaches. Yet power remains limited when sample sizes are small and unbalanced across treatment arms. Power can be improved through adaptive enrichment of the sample size, especially when treatment arms are small and unbalanced. We propose an adaptive design to improve power for detecting a predictive effect when sample sizes are small. Existing adaptive biomarker designs largely focus on enrichment of the trial, for example, adjusting enrolment criteria based on an assessment of the treatment‐biomarker interaction at interim, or refining the biomarker threshold used to segregate the population into biomarker positive or negative (i.e., those patients more or less likely to respond to the treatment). Few designs explicitly address the task of formally declaring a predictive effect of a biomarker using an interim analysis. The interim analysis framework enables a more reliable assessment of a biomarker's predictive effect by introducing a pre‐planned evaluation at the originally intended sample size of a study which may otherwise be underpowered due to the limited number of patients. Based on the interim results, the trial may (i) already have sufficient evidence to declare a biomarker as predictive, (ii) be terminated early due to a clear lack of evidence for a predictive effect, or (iii) enter an “expansion phase”, where additional cohort of patients are recruited to improve the power for final analysis. The proposed framework addresses key methodological challenges, including interim decision rules, determining the magnitude and allocation of post‐interim sample size increases, controlling the Type I error rate, and achieving meaningful gains in statistical power at the final analysis. The impact of an unknown biomarker distribution is also considered. These challenges are explored through simulation studies, where properties of the interim and final analyses are presented under various design configurations (where the decision bounds and size of the expansion are altered) and scenarios, in which the true predictive and prognostic effects of the biomarker are varied. Evaluated metrics include statistical power, Type I error control, and interim decision characteristics. The results inform the design of trials incorporating interim analyses to assess the predictive effect of a biomarker, enabling statistically efficient and well‐calibrated decision‐making.
JASA Other · 发表于 2026-09-08,收录于 2026-07-24
Not available
摘要
When designing a randomized experiment, one way to ensure treatment and control groups exhibit similar covariate distributions is to randomize treatment until some prespecified level of covariate balance is satisfied; this strategy is known as rerandomization. Most rerandomization methods utilize balance metrics based on a quadratic form vTAv, where v is a vector of covariate mean differences and A is a positive semi-definite matrix. In this work, we derive general results for treatment-versus-control rerandomization schemes that employ quadratic forms for covariate balance. In addition to allowing researchers to quickly derive properties of rerandomization schemes not previously considered, our theoretical results provide guidance on how to choose A in practice. We find the Mahalanobis and Euclidean distances optimize different measures of covariate balance. Furthermore, we establish how the covariates’ eigenstructure and their relationship to the outcomes dictate which matrix A yields the most precise difference-in-means estimator for the average treatment effect. We find the Euclidean distance is minimax optimal, in the sense that the difference-in-means estimator’s precision is never too far from the optimal choice. We verify our theoretical results via simulation and a real data application, and demonstrate how the choice of A impacts the variance reduction of rerandomized experiments. *(abstract via OpenAlex)*
JASA Optimization & Learning Theory · 发表于 2026-09-08
Yuanlu Bai, Henry Lam, Xinyu Zhang
摘要
Conventional methods for extreme event estimation rely on well-chosen parametric models asymptotically justified from extreme value theory (EVT). These methods, while powerful and theoretically grounded, could however encounter a bias-variance tradeoff that becomes more difficult to tackle when the data size is too small, deteriorating the reliability of the tail estimation. In this paper, we study a framework based on the recently surging literature of distributionally robust optimization. This approach can be viewed as a nonparametric alternative to conventional EVT, by imposing general shape belief on the tail instead of parametric assumption and using worst-case optimization as a resolution to handle the nonparametric uncertainty. We explain how this approach bypasses the bias-variance tradeoff in EVT. On the other hand, we face a conservativeness-variance tradeoff which we describe how to tackle. We also demonstrate computational tools for the involved optimization problems and compare our performance with conventional EVT across a range of numerical examples. *(abstract via OpenAlex)*
SMMR Survival Analysis Clinical Trials Bayesian Methods · 发表于 2026-09-08
Wenyun Yang, Bosheng Li, Fangrong Yan
摘要
Identifying the optimal dose–schedule regimen in early-phase oncology trials is complicated by competing risks, such as disease progression (DP) and dose-limiting toxicity (DLT). Many existing dose-finding methods fail to adequately address these events or accommodate varying administration schedules. We propose CR-EffTox, a Bayesian adaptive phase I/II trial design that jointly models time-to-event DLT and DP using cause-specific hazard functions. Besides, the model proposed allows for dynamic information borrowing to account for associations among dose–schedule regimes. To guide regimen selection, a novel satisfaction score derived from cause-specific survival curves is introduced to quantify the benefit–risk trade-off. The operating characteristics of the method are evaluated through extensive simulations. The method generally outperforms methods that ignore competing risks or information borrowing, substantially improving correct selection probability and enhancing patient safety by reducing allocation to suboptimal regimens.
SiM Other · 发表于 2026-09-07
James P. Long, Abhishikta Roy, Ehsan Irajizad, Kim‐Anh Do, Yu Shen
摘要
In meta‐analytic modeling, the functional relationship between a primary and surrogate endpoint is estimated using summary data from a set of completed clinical trials. Parameters in the meta‐analytic model are used to assess the quality of the proposed surrogate. Recently, meta‐analytic models have been employed to evaluate whether late‐stage cancer incidence can serve as a surrogate for cancer mortality in cancer screening trials. A major challenge in meta‐analytic models is that uncertainty of trial‐level estimates affects the evaluation of surrogacy, since each trial provides only estimates of the primary and surrogate endpoints rather than their true parameter values. In this work, we show via simulation and theory that trial‐level estimate uncertainty may bias the results of meta‐analytic models toward positive findings of the quality of the surrogate. We focus on cancer screening trials and the late‐stage incidence surrogate. We reassess correlations between primary and surrogate endpoints in Ovarian cancer screening trials. Our findings indicate that completed trials provide limited information regarding quality of the late‐stage incidence surrogate. These results support restricting meta‐analytic regression usage to settings where trial‐level estimate uncertainty is incorporated into the model.
SiM Causal Inference · 发表于 2026-09-06
Kelly C. Kung, Natasha K. Martin, Judith J. Lok
摘要
Recent works in econometrics have shown that there can be issues with applying a constant treatment effect model in longitudinal settings with staggered treatment and heterogeneous treatment effects. We focus on the issue that the estimated constant treatment effect may be a weighted average, with some negative weights, of treatment effects that are heterogeneous across treatment durations. When this issue arises, the estimated constant treatment effect and estimated heterogeneous treatment effects may result in conflicting results. Through the example of estimating the effect of drug‐induced homicide (DIH) prosecutions reported by media on unintentional drug‐overdose deaths in the United States, we illustrate how the negative weighting issue can lead to conflicting results in practice. Moreover, although research has shown that the negative weight issue may arise in linear regression models, we show this issue may also arise in logistic regression models. Using a linear link, we estimated a constant treatment effect risk ratio of 0.977 (95% CI: [0.866, 1.101]) and an average risk ratio of 0.728 (range: 0.507–0.979) over different treatment durations. Using a logistic link, we estimated a constant treatment risk ratio effect of 1.064 (95% CI: [0.972, 1.165]) and an average risk ratio of 0.739 (range: 0.538–1.008) over different treatment durations. Under both models, the estimated constant treatment effect is either smaller in magnitude or has a different sign than almost all estimated heterogeneous treatment effects, suggesting a negative weighting issue is present. Our results suggest additional care is needed when applying constant treatment effect models in longitudinal settings.
SiM Diagnostics & Prediction High-Dimensional Nonparametric & Semiparametric · 发表于 2026-09-06
María Xosé Rodríguez‐Álvarez, Vanda Inácio
摘要
The identification of biomarkers with high predictive accuracy is a crucial task in medical research, as it can aid clinicians in making early decisions, thereby reducing morbidity and mortality in high‐risk populations. Time‐dependent receiver operating characteristic (ROC) curves are the main tool used to assess the accuracy of prognostic biomarkers for outcomes that evolve over time. Recognising the need to account for patient heterogeneity when evaluating the accuracy of a prognostic biomarker, we introduce a novel penalised‐spline‐based estimator of the time‐dependent ROC curve that accommodates a possible modifying effect of covariates. We consider flexible models for both the hazard function of the event time given the covariates and biomarker and for the location‐scale regression model of the biomarker given covariates, enabling the accommodation of non‐proportional hazards and nonlinear effects through penalised splines, thus overcoming limitations of earlier methods. The simulation study demonstrates that our approach successfully recovers the true functional form of the covariate‐specific time‐dependent ROC curve and the corresponding area under the curve across a variety of scenarios. Comparisons with existing methods further show that our approach performs favourably in multiple settings. Our approach is applied to evaluate the ability of the Global Registry of Acute Coronary Events risk score to predict mortality over different time periods after discharge in patients who have suffered an acute coronary syndrome and to investigate how this ability may vary with the left ventricular ejection fraction. An R package, CondTimeROC , implementing the proposed method is provided.
SiM Survival Analysis High-Dimensional · 发表于 2026-09-06
Jie He, Yiyu Li, Yan Hou
摘要
With the rapid advancement of high‐throughput technologies, feature screening methods have attracted increasing attention for analyzing ultra‐high‐dimensional data. Motivated by the widespread availability of meaningful grouping structures in biomedical applications, such as brain imaging and gene expression studies, we propose a novel group‐structure‐guided (GSG) feature screening method for survival outcomes. The proposed approach incorporates prior grouping information among predictors and accommodates both disjoint and overlapping group structures. Furthermore, a combined GSG (C‐GSG) extension is developed to integrate multiple grouping schemes. We establish the sure screening properties of the proposed procedures and demonstrate through extensive simulation studies that incorporating informative group structures can improve screening performance, particularly under challenging censoring scenarios. The proposed method is further applied to a TCGA breast cancer dataset, where pathway information is utilized to identify genes associated with patient survival outcomes.
AoS Functional Data Nonparametric & Semiparametric · 发表于 2026-09-03
Jianbin Tan, Anru Zhang
中文概述(非原文摘要)
针对隐私限制、稀疏不规则采样、无穷维、非高斯结构等挑战,提出 Smooth Flow Matching(SFM)框架,用于功能型数据的生成建模。方法基于流匹配思想构建半参数 copula 流,不依赖高斯性或低秩假设即可生成无穷维功能数据。作者将 SFM 应用于 MIMIC-IV 电子病历(EHR)的临床轨迹(纵向)数据生成,展示其为下游统计任务生成高质量替代数据的能力。(归入本类是因应用场景为纵向 EHR 数据生成;方法本身也属于功能数据分析/生成模型,跨类,供参考)
AoS Functional Data Machine Learning Nonparametric & Semiparametric · 发表于 2026-09-03
Jianbin Tan, Anru Zhang
摘要
Functional data, i.e., smooth random functions observed over a continuous domain, are increasingly available in areas such as biomedical research, health informatics, and epidemiology. However, effective statistical analysis for functional data is often hindered by challenges such as privacy constraints, sparse and irregular sampling, infinite dimensionality, and non-Gaussian structures. To address these challenges, we introduce a novel framework named Smooth Flow Matching (SFM), tailored for generative modeling of functional data to enable statistical analysis without exposing sensitive real data. Built upon flow-matching ideas, SFM constructs a semiparametric copula flow to generate infinite-dimensional functional data, free from Gaussianity or low-rank assumptions. It is computationally efficient, handles irregular observations, and guarantees the smoothness of the generated functions, offering a practical and flexible solution in scenarios where existing deep generative methods are not applicable. Through extensive simulation studies, we demonstrate the advantages of SFM in terms of both synthetic data quality and computational efficiency. We then apply SFM to generate clinical trajectory data from the MIMIC-IV patient electronic health records (EHR) longitudinal database. Our analysis showcases the ability of SFM to produce high-quality surrogate data for downstream statistical tasks, highlighting its potential to boost the utility of EHR data for clinical applications." (Placed here because the application is longitudinal EHR trajectory data; the method itself is a generative model for functional data, so it also straddles Others — flagged for reference.)
SiM Causal Inference High-Dimensional · 发表于 2026-09-03,收录于 2026-10-20
Zhaoyang Li, Lulu Pan, Yongfu Yu, Guoyou Qin, Bo Fu
摘要
Mediation analysis is a powerful tool for elucidating the causal mechanisms by which exposures influence outcomes through mediators. However, conventional approaches often yield biased estimates of mediation effects in scenarios involving high-dimensional exposures and high-dimensional mediators, alongside a small number of pervasive hidden confounders that simultaneously affect the exposures, mediators, and outcome or the exposures and outcome. To address these challenges, we propose a deconfounded-debiased method for estimation and inference in high-dimensional mediation analysis based on the difference-in-coefficients strategy. This approach effectively corrects biases arising from both pervasive hidden confounders and high-dimensionality without requiring prior knowledge of hidden confounders or a sparse precision matrix assumption. We establish the asymptotic normality of the proposed estimators for both direct and indirect effects, and develop hypothesis testing procedures that asymptotically achieve validity and power lower bounds. Simulation experiments demonstrate our method's superior finite-sample performance in both estimation and inference, especially in the presence of pervasive hidden confounding. We also apply the proposed method to real data from the Alzheimer's Disease Neuroimaging Initiative to identify serum metabolites that influence Alzheimer's disease progression through DNA methylation pathways.
AoS Causal Inference Spatial & Time Series · 发表于 2026-09-03
Abhirup Datta, Michael L. Stein
摘要
The problem of estimating the slope parameter in regression between two spatial processes under confounding by an unmeasured spatial process has received widespread attention in the recent statistical literature. Yet, a fundamental question remains unresolved: when is this slope consistently estimable under spatial confounding, with existing insights being largely empirical or estimator-specific. In this manuscript, we characterize conditions for consistent estimability of the regression slope between Gaussian random fields (GRFs), the common stochastic model for spatial processes, under spatial confounding. Under fixed-domain (infill) asymptotics, we give sufficient conditions for consistent estimability using a novel characterization of the regression slope as the ratio of principal irregular terms of covariances, dictating the relative local behavior of the exposure and confounder processes. When estimability holds, we provide consistent estimators of the slope using local differencing (taking discrete differences or Laplacians of the processes of suitable order). Using functional analysis results on Paley-Wiener spaces, we then provide an easy-to-verify necessary condition for consistent estimability of the slope in terms of the relative spectral tail decays of the confounder and exposure. As a by-product, we establish a novel and general spectral condition on the equivalence of measures on the paths of multivariate GRFs with component fields of varying smoothnesses, a result of independent importance. Our estimability results or estimators do not rely on specific parametric models for the covariance functions. We show that for many covariance classes like the Matérn, power-exponential, generalized Cauchy, and coregionalization families, the necessary and sufficient conditions become identical, thereby providing a complete characterization of consistent estimability of the slope under spatial confounding for these processes. The results are extended to accommodate measurement error using local-averaging-and-differencing based estimators. Finite sample behavior is explored via numerical experiments." (This is fundamentally a spatial-statistics identifiability result about confounding adjustment; placed in Causal Inference for its direct relevance to spatial confounding, though it is not a classical treatment-effect estimation paper — flagged for your own judgment.)
AoS Bayesian Methods · 发表于 2026-09-03
Martin Chak, Giacomo Zanella
摘要
Markov Chain Monte Carlo (MCMC), Laplace approximation (LA) and variational inference (VI) methods are popular approaches to Bayesian inference, each with trade-offs between computational cost and accuracy. However, a theoretical understanding of these differences is missing, particularly when both the sample size n and the dimension d are large. LA and Gaussian VI are justified by Bernstein-von Mises (BvM) theorems, and recent work has derived the characteristic condition n≫d² for their validity, improving over the condition n≫d³. In this paper, we show for linear, logistic and Poisson regression that for n≳d, MCMC attains the same complexity scaling in n, d as first-order optimization algorithms, up to sub-polynomial factors. Thus MCMC is competitive with LA and Gaussian VI in complexity, under a scaling between n and d more general than BvM regimes. Our complexities apply to appropriately scaled priors that are not necessarily Gaussian-tailed, including Student-t and flat priors, with log-posteriors that are not necessarily globally concave or gradient-Lipschitz.
SiM Bayesian Methods Meta-Analysis & Data Integration Survey & Sampling · 发表于 2026-09-03
Zixuan Feng, Qiushi Chen, Paul Griffin, Le Bao
摘要
Drug overdose deaths, including from opioids, remain a significant public health threat to the United States (US). To abate the harms of opioid misuse, understanding its prevalence at the local level is crucial for stakeholders in communities to develop response strategies that effectively use limited resources. Although there exist several state‐specific studies that provide county‐level prevalence estimates, such estimates are not widely available across the country, as the datasets used in these studies are not always readily available in other states, which, therefore, has limited the wider applications of existing models. To fill this gap, we propose a Bayesian multi‐state data integration approach that fully utilizes publicly available data sources to estimate county‐level opioid misuse prevalence for all counties in the US. The hierarchical structure jointly models opioid misuse prevalence and overdose death outcomes, leverages existing county‐level prevalence estimates in limited states and state‐level estimates from national surveys, and accounts for heterogeneity across counties and states with counties' covariates and mixed effects. Furthermore, our parsimonious and generalizable modeling framework employs horseshoe+ prior to flexibly shrink coefficients and prevent overfitting, ensuring adaptability as new county‐level prevalence data in additional states become available. Using real‐world data, our model shows high estimation accuracy through cross‐validation and provides nationwide county‐level estimates of opioid misuse for the first time.
SMMR Clinical Trials Bayesian Methods Causal Inference · 发表于 2026-09-02
Zhi Cao, Pavel Mozgunov, Haiyan Zheng
摘要
Basket trials have gained increasing attention for their efficiency, as multiple patient subgroups are evaluated simultaneously. Conducted basket trials focus primarily on establishing the early efficacy of a treatment, yet continued monitoring of toxicity is essential. In this article, we propose two Bayesian hierarchical models that enable bivariate analyses of toxicity and efficacy, while accounting for heterogeneity present in the treatment effects across patient subgroups. Specifically, one assumes the subgroup-specific toxicity and efficacy treatment effects, as a parameter vector, can be exchangeable or non-exchangeable; the other allows either the toxicity or efficacy parameters specific to the subgroups, to be exchangeable or non-exchangeable. The bivariate exchangeability and non-exchangeability distributions introduce a correlation parameter between treatment effects, while we stipulate a zero correlation when only toxicity or efficacy parameters are exchangeable. Simulation results show that our models perform robustly under different scenarios compared to the standard Bayesian hierarchical model and the stand-alone analyses, especially in producing higher power when the subgroup-specific effects are exchangeable in toxicity or efficacy only. When considerable correlation between the toxicity and efficacy effects exists, our methodology gives small error rates and greater power than alternatives that analyse toxicity and efficacy by parts.
SiM Survival Analysis Networks & Graphs · 发表于 2026-09-02,收录于 2026-09-17
Not retrieved — Wiley's article page and PMC/PubMed mirrors were reachable in search-result snippets but returned a CAPTCHA challenge page on fetch; no author names could be confirmed this run.
SiM Bayesian Methods · 发表于 2026-09-01
Yuansong Zhao, Ying Yuan, Ram Tiwari, Samiran Ghosh
摘要
Non‐inferiority trials play a central role in clinical research by demonstrating that an experimental treatment is not unacceptably worse than an established reference treatment when superiority is unlikely, but the new treatment offers other advantages, such as reduced toxicity, easier administration, lower cost, or improved adherence. These trials are typically designed as active control studies, making historical data from previous clinical trials or real‐world evidence readily available. A key challenge, however, is how to appropriately incorporate multiple heterogeneous historical datasets into the design and analysis of a non‐inferiority trial, as each source may differ in relevance, quality, and similarity to the current study. Moreover, a conventional two‐arm non‐inferiority trial lacks a placebo or standard of care control, requiring the reference treatment effect to be justified using external evidence. When ethically and practically feasible, including a placebo arm allows assessment of assay sensitivity and provides internal validation of the reference treatment effect, thereby strengthening the credibility of the non‐inferiority conclusion. In this article, we propose two novel Bayesian self‐adapting priors, the Additive Self‐Adapting Mixture (ASAM) prior and the Cumulative Self‐Adapting Product (CSAP) prior, to incorporate information from multiple historical reference and placebo studies in three‐arm non‐inferiority trials. The ASAM prior constructs study‐specific priors and combines them through an adaptively weighted mixture, whereas the CSAP prior uses a cumulative product formulation with adaptive study‐specific weights. Both approaches dynamically borrow information by assigning greater weight to historical studies that are more compatible with the current trial while down‐weighting less comparable studies, thereby mitigating the impact of between‐study heterogeneity. Extensive simulation studies demonstrate that the proposed methods maintain appropriate control of the Type I error rate while achieving substantial gains in statistical power, providing a flexible and robust framework for Bayesian analysis of three‐arm non‐inferiority trials.
JASA Other · 发表于 2026-09-01
Stefano Giglio, Dacheng Xiu, Dake Zhang
摘要
In economic forecasting, principal component analysis (PCA) has been the most prevalent approach to the recovery of factors, which summarize information in a large set of predictors. Nevertheless, the theoretical justification of this approach often relies on a convenient and critical assumption that factors are pervasive. To incorporate information from weaker factors, we propose a new prediction procedure based on supervised PCA, which iterates over selection, PCA, and projection. The selection step finds a subset of predictors most correlated with the prediction target, whereas the projection step permits multiple weak factors of distinct strength. We justify our procedure in an asymptotic scheme where both the sample size and the cross-sectional dimension increase at potentially different rates. Our empirical analysis highlights the role of weak factors in predicting inflation, industrial production growth, and changes in unemployment. *(abstract via OpenAlex)*
SiM Clinical Trials · 发表于 2026-08-31
Ying Zhang, John S. Preisser
摘要
Generalized estimating equations (GEE) produce population‐averaged estimates of treatment effects in marginal mean models for correlated count outcomes, when intra‐cluster correlations are considered as nuisance parameters. For joint inference of marginal means and correlations, paired estimating equations have been proposed. With a small number of clusters, matrix‐adjusted estimating equations (MAEE) were introduced to correct finite‐sample bias in correlation parameter estimates. This article extends the GEE/MAEE method by adding a third estimating equation for the scale parameter (3EE/MAEE) and demonstrates its superior performance for correlated count outcomes. In simulations, 3EE/MAEE reduced bias of ICC estimates and better maintained the nominal coverage of confidence intervals compared to its uncorrected counterpart. The performance of different bias‐corrected sandwich variance estimators as well as working negative binomial (NB) and Poisson models is also evaluated. The 3EE/MAEE method is applied to overdispersed correlated count outcomes from a real‐world, stepped wedge cluster randomized trial.
Biometrics Networks & Graphs Bayesian Methods Genetics & Omics · 发表于 2026-08-31,收录于 2026-09-17
Weixuan Zhu, Fan Liao, Yang Ni
摘要
Graph-based denoising is a critical preprocessing step for analyzing noisy data, particularly in genomic applications where gene regulatory networks exhibit inherent directional dependencies. This paper introduces a directed acyclic graph trend filtering (GTF) framework that leverages novel higher-order Bayesian networks and graphical shrinkage processes to enhance local adaptivity in signal smoothing along the directed edges of a graph. Unlike traditional GTF, which is based on undirected graphs, the proposed method explicitly respects the directional structure of graphs, improving interpretability and accuracy in capturing dependencies. We employ a Hamiltonian Monte Carlo algorithm for efficient posterior inference. Through simulations and genomic applications, the proposed method outperforms a state-of-the-art GTF algorithm in terms of mean squared error reduction and signal-to-noise ratio improvement, demonstrating its utility in recovering true signals while accounting for meaningful structural information." *Publication/online date: 31 August 2026*
JASA Testing & Uncertainty · 发表于 2026-08-31,收录于 2026-07-24
Not available
摘要
This paper develops a flexible distribution-free method for collective outlier detection and enumeration, designed for situations in which the presence of outliers can be detected powerfully even though their precise identification may be challenging due to the sparsity, weakness, or elusiveness of their signals. This method builds upon recent developments in conformal inference and integrates classical ideas from other areas, including multiple testing, locally most powerful and adaptive rank tests, and non-parametric large-sample asymptotics. The key innovation lies in developing a principled and effective approach for automatically choosing the most appropriate machine learning classifier and two-sample testing procedure for a given data set. The performance of our method is investigated through extensive empirical demonstrations, including an analysis of the LHCO high-energy particle collision data set. *(abstract via OpenAlex)*
JASA Testing & Uncertainty · 发表于 2026-08-31,收录于 2026-07-24
Not available
摘要
Multivariate histograms are difficult to construct due to the curse of dimensionality. Motivated by k-d trees in computer science, we show how to construct an efficient data-adaptive partition of Euclidean space that possesses the following two properties: With high confidence the distribution from which the data are generated is close to uniform on each rectangle of the partition; and despite the data-dependent construction we can give guaranteed finite sample simultaneous confidence intervals for the probabilities (and hence for the average densities) of each rectangle in the partition. This partition will automatically adapt to the sizes of the regions where the distribution is close to uniform. The methodology produces confidence intervals whose widths depend only on the probability content of the rectangles and not on the dimensionality of the space, thus avoiding the curse of dimensionality. Moreover, the widths essentially match the optimal widths in the univariate setting. The simultaneous validity of the confidence intervals allows to use this construction, which we call Beta-trees, for various data-analytic purposes. We illustrate this by using Beta-trees for visualizing data and for multivariate mode-hunting. *(abstract via OpenAlex)*
Biometrics Bayesian Methods Networks & Graphs · 发表于 2026-08-31,收录于 2026-09-17
Simiao Gao, Sungduk Kim, Ming-Hui Chen, Arvind K Shah, Jianxin Lin, Joseph G Ibrahim
摘要
In this paper, we propose a Bayesian multivariate network meta-regression model to compare multiple treatments used to treat cardiovascular and diabetes diseases, where the multivariate aggregate outcomes include low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides. We assume a log-linear regression model for the standard deviation of the treatment random effects to overcome the difficulty that some treatments may present only in a single study. As the within-study sample covariance matrix is partially observed or completely missing and the within-study sample correlations are not observed at all, we postulate a hierarchical structure on the unknown within-study covariance matrices. We further develop a Markov chain Monte Carlo sampling algorithm to sample from the posterior distribution and a Monte Carlo procedure to rank the treatment effects for the multivariate outcomes. DIC is used for model comparison. Two variations of DIC are further developed to quantify (i) the overall improvement in the fit and (ii) the gain in the fit of each outcome due to the multivariate model versus the univariate model alone. A detailed analysis of the aggregate data from real randomized controlled trials is carried out to further demonstrate the proposed methodology." *Publication/online date: 31 August 2026*
JASA Causal Inference Networks & Graphs · 发表于 2026-08-31,收录于 2026-07-24
Not available
摘要
Randomized experiments are the gold standard for causal inference. However, traditional assumptions, such as the Stable Unit Treatment Value Assumption (SUTVA), often fail in real-world settings where interference between units is present. Network interference, in particular, has garnered significant attention. Structural models, like the linear-in-means model, are commonly used to describe interference, but they rely on the correct specification of the model, which can be restrictive. Recent advancements in the literature, such as the Approximate Neighborhood Interference (ANI) framework, offer more flexible approaches by assuming negligible interference from distant units. In this paper, we introduce a general framework for regression adjustment in network experiments under the ANI assumption. This framework expands traditional regression adjustment by accounting for imbalances in network-based covariates, ensuring precision improvement, and providing shorter confidence intervals. We establish the validity of our approach using a design-based inference framework, which relies solely on the randomization of treatment assignments for inference without requiring correctly specified outcome models. *(abstract via OpenAlex)*
SiM Other · 发表于 2026-08-30
Cedric Neumann, Andrew Anthony Matas, Jeffrey Jamison Geppert
摘要
The selection and use of quality measures in value‐based payment rely on single‐period methods that conflate sampling noise with genuine within‐provider year‐to‐year execution variability, producing assessments that are unstable across years and dependent on patient volume. We introduce a Longitudinal Beta‐Binomial model, which separates three sources of variability simultaneously and produces a year‐invariant measure‐level assessment and a volume‐independent provider‐specific assessment . Applied to five years of data (program years 2021–2025) for 744 providers on two CMS mental health quality measures, the analysis yields a striking reversal: under the standard Beta‐Binomial framework, FUH‐30 appears far more discriminating than READM‐30‐IPF (–0.87 vs 0.51–0.63 per year); separating execution variability from sampling noise reverses this conclusion ( [0.598, 0.642] for FUH‐30 vs [0.730, 0.784] for READM‐30‐IPF, 95% posterior credible intervals), because FUH‐30's year‐to‐year provider instability is three times larger than its sampling noise. The framework proposes three requirements simultaneously: discriminability ( can separate good from poor health‐care providers and is year‐invariant where swings substantially across years); fairness (both and are independent of patient volume, removing the structural disadvantage faced by small and rural providers); and actionability ( distinguishes consistently substandard from erratic providers, enabling targeted intervention and more honest measure adoption decisions).
JASA Econometrics & Economics · 发表于 2026-08-28
David L. Donoho, Jian Kang, Xihong Lin, Bhramar Mukherjee, Dan Nettleton, Rebecca Nugent, Abel Rodriguez, Eric P. Xing, Tian Zheng, Hongtu Zhu
摘要
This perspective article distills themes from the 2024 JSM town hall, Statistics in the Age of AI, where panelists discussed how the field should evolve as foundation models, large-scale empirical modeling, and data-intensive infrastructures reshape science and society. Rather than a transcript or comprehensive survey, the article offers a forward-looking perspective grounded in the town hall discussion and the authors’ reflections. We organize the discussion around five recurring questions: (i) disciplinary culture and incentives, (ii) the role of data curation and annotation, (iii) engagement with modern empirical modeling, (iv) training for large-scale AI applications, and (v) partnerships with key AI stakeholders. We emphasize that statistics already leads in areas such as uncertainty quantification, study design, evaluation, and inference, while arguing that some parts of the field could engage more deeply with data engineering, cloud-scale computation, and end-to-end AI systems. We conclude with pragmatic recommendations for training, incentives, and collaboration so that statisticians can help shape the data-centric future. *(abstract via OpenAlex)*
JASA Meta-Analysis & Data Integration · 发表于 2026-08-28
T. Tony Cai, Dongwoo Kim, Yicheng Li, Dongdong Xiang
摘要
Transfer learning, which leverages auxiliary data to improve inference in a target domain, has become a powerful tool in machine learning. In this work, we study minimax and adaptive estimation of large bandable covariance matrices under a transfer learning framework.We first establish the minimax rate of convergence under squared spectral norm loss and propose a rate-optimal estimator. Our analysis reveals phase transitions determined by the source-target disparity, the source sample size, the dimension, and the two smoothness indices. We then develop an adaptive estimator, a fully data-driven procedure that does not require the unknown smoothness and disparity parameters. In most regimes, it directly attains the minimax optimal rate without additional cost of adaptation.Simulation studies support our theoretical results and demonstrate the practical effectiveness of the proposed adaptive procedure. We further illustrate its utility in a phoneme classification task, where incorporating related phonemes as auxiliary data significantly improves classification performance. *(abstract via OpenAlex)*
SiM High-Dimensional Testing & Uncertainty · 发表于 2026-08-28
Shuai Sun, Valeria R. Mas, Kellie J. Archer
摘要
Mixed‐type outcome data occur when the outcome variable's distribution is a mixture of both continuous and discrete ordinal variables. Such mixed‐type outcomes are common in biomedical, psychological, and the health sciences, particularly for variables having either a detection or quantitation limit. When interest lies in identifying a combination of genomic features associated with a mixed‐type outcome, any method used would require a variable selection strategy for high‐dimensional data. Unfortunately, few variable selection methods exist for modeling a mixed‐type outcome when the covariate space is high dimensional. This study develops a high‐dimensional penalized cumulative probability model (CPM), to allow for the identification of genomic features associated with mixed‐type outcome of interest. We demonstrated how such model may be estimated using the iterative penalization procedure—the generalized monotone incremental forward stagewise (GMIFS) algorithm. The Model‐X knockoffs procedure was combined with the estimation algorithm to control the false discovery rates (FDR) when performing variable selection. Through extensive simulation studies, our penalized CPM was shown to outperform alternative methods in terms of controlled variable selection performance by achieving high statistical power with the FDR being controlled at the target level. We demonstrate the utility of our method by applying it to predict estimated glomeruli filtration rate (eGFR) in kidney transplant recipients at 24 months post‐transplant using baseline gene expression data as predictors. Our CPM model identified five genes associated with this mixed‐type outcome which have important links to renal disease, which may provide prognostic guidance for kidney transplantation recipients.
SiM Genetics & Omics · 发表于 2026-08-28
Christina Y. Feng, Pierre‐Emmanuel Sugier, Nan Zou, Benoit Liquet
摘要
Genome‐wide association studies (GWAS) have shown that pleiotropy, whereby a single genetic variant or gene influences multiple traits, is common in complex human diseases. Detecting cross‐phenotype associations from GWAS summary statistics remains challenging because of small effect sizes, extensive multiple testing, heterogeneous effects, and possible differences in effect direction across traits. Methods that jointly analyze multiple traits can improve the ability to detect pleiotropic signals while retaining the practical advantages of summary statistic‐based analyses. Although a range of statistical approaches has been developed for this purpose, practical guidance on their application, assumptions, and interpretation remains limited. This tutorial reviews several widely used methods for pleiotropy detection from GWAS summary statistics, including ASSET, PLACO, GPA, CPBayes, and GCPBayes, and demonstrates their application using breast and thyroid cancer datasets. We also highlight the importance of accounting for effect heterogeneity, correlation, and biological group structure at the gene and pathway levels in the detection and interpretation of pleiotropic association signals.
JASA Machine Learning · 发表于 2026-08-27
Jin Zhu, Xin Zhou, Jiaang Yao, Gholamali Aminian, Omar Rivasplata, Simon Little, Lexin Li, Chengchun Shi
摘要
Offline reinforcement learning aims to learn an optimal policy from pre-collected data. However, it faces challenges of distributional shift, where the learned policy may encounter unseen scenarios not covered in the offline data. Additionally, numerous applications suffer from a scarcity of labeled reward data. Relying on labeled data alone often leads to a narrow state-action distribution, further amplifying the distributional shift, and resulting in suboptimal policy learning. To address these issues, we first recognize that the volume of unlabeled data is typically substantially larger than that of labeled data. We then propose a semi-pessimistic reinforcement learning method to effectively leverage abundant unlabeled data. This approach offers several advantages. It considerably simplifies the learning process, as it seeks a lower bound of the reward function, rather than that of the Q-function or state transition function. It is highly flexible, and can be integrated with a range of model-free and model-based reinforcement learning algorithms. It enjoys the guaranteed improvement when utilizing vast unlabeled data, but requires less restrictive conditions. We compare the method with a number of alternative solutions, both analytically and numerically, and demonstrate its clear competitiveness. We further illustrate with an application to adaptive deep brain stimulation for Parkinson’s disease. *(abstract via OpenAlex)*
JASA High-Dimensional · 发表于 2026-08-27
Jing Zeng, Xin Zhang, Ning Hao
摘要
Motivated by exploratory data analysis, sufficient dimension reduction (SDR) methods, especially inverse regression methods such as sliced inverse regression (SIR) and sliced averaged variance estimation (SAVE), have been central to multivariate analysis for more than three decades. Despite their popularity, the extension of these methods to high-dimensional settings remains challenging. This paper addresses the computational and theoretical limitations of the less explored second-order SDR methods in high dimensions. We introduce a novel approach for sparse subspace estimation that utilizes quadratic convex optimization and leverages the group structure of tensor parameters, achieving significant parameter reduction. The proposed two-step estimator achieves consistency in dimension selection, variable selection, and subspace estimation at a high convergence rate under mild conditions. The effectiveness and efficiency of the proposed method are further demonstrated through extensive simulation studies and real data examples. Additionally, the proposed sparse second-order SDR techniques are applied to quadratic discriminant analysis (QDA) problems and provide practitioners with a sparse projective classification method with theoretical guarantees and strong empirical performance. *(abstract via OpenAlex)*
JASA High-Dimensional · 发表于 2026-08-27
Ilyes Hammouda, Mohamed Ndaoud, Abd-Krim Seghouane
摘要
Convex and penalized robust regression methods often suffer from a persistent bias induced by large outliers, limiting their effectiveness in adversarial or heavy-tailed settings. In this work, we study a smooth redescending non-convex M-estimator, specifically the Welsch estimator, and show that it can eliminate this bias whenever it is statistically identifiable. We focus on high-dimensional linear regression under adversarial contamination, where a fraction of samples may be corrupted by an adversary with full knowledge of the data and underlying model.A central technical contribution of this paper is a practical algorithm that provably finds a statistically valid solution to this non-convex problem. We show that the Welsch objective remains locally convex within a well-characterized basin of attraction, and our algorithm is guaranteed to converge into this region and recover the desired estimator. We establish three main guarantees: (a) non-asymptotic minimax-optimal deviation bounds under contamination, (b) improved unbiasedness in the presence of large outliers, and (c) asymptotic normality, yielding statistical efficiency as the sample size grows. Finally, numerical experiments on synthetic and real datasets illustrate substantial bias reduction under directional adversarial contamination in simulations and broadly comparable predictive performance on the real-data benchmarks. *(abstract via OpenAlex)*
JASA Survival Analysis Nonparametric & Semiparametric · 发表于 2026-08-27
Bo Han, Ingrid Van Keilegom, Xiaoguang Wang
摘要
Quantile regression is emerging as a valuable statistical tool for exploring complete information on the exposure-outcome relationship. This paper investigates a novel inference procedure for quantile regression models to analyze survival data with a cure fraction. A two-component mixture cure model is used, in which the cure fraction follows a logistic model and the uncured individuals follow a linear quantile regression model. Our main interest lies in the estimation of regression coefficients in the latter model. This is achieved by minimizing a loss function that has three building blocks: (1) the check function, commonly used in quantile regression, (2) a first weight function that redistributes the weight of censored observations, and (3) a second weight function that accounts for the latent cure status. The minimization of this loss function leads to a computationally simple estimation procedure for quantile regression parameters. The approach of dimension reduction is employed to circumvent the curse of dimensionality. Asymptotic properties of the resulting estimators are established, including the consistency and weak convergence. Simulation studies, including homogeneous and heterogeneous error cases, demonstrate the advantageous empirical performance of the proposed method. The analysis of a breast cancer study illustrates the practical utility of our cure rate quantile regression. *(abstract via OpenAlex)*
JASA Testing & Uncertainty · 发表于 2026-08-27
Stephen Bates, Michael I. Jordan, Michael Sklar, Jake A. Soloff
摘要
Consider the relationship between a regulator (the principal) and an experimenter (the agent) such as a pharmaceutical company. The pharmaceutical company wishes to sell a drug for profit, whereas the regulator wishes to allow only efficacious drugs to be marketed. The efficacy of the drug is not known to the regulator, so the pharmaceutical company must run a costly trial to prove efficacy to the regulator. Critically, the statistical protocol used to establish efficacy affects the behavior of a strategic, self-interested agent; a lower standard of statistical evidence incentivizes the agent to run more trials that are less likely to be effective. The interaction between the statistical protocol and the incentives of the pharmaceutical company is crucial for understanding this system and designing protocols with high social utility. In this work, we discuss how the regulator can set up a protocol with payoffs based on statistical evidence. In particular, we study a setting where the regulator can limit the profit of the company, and show that the optimal protocols are instances of e-values, shedding new light on this statistical tool. *(abstract via OpenAlex)*
JASA Functional Data Networks & Graphs · 发表于 2026-08-27,收录于 2026-07-24
Not available
摘要
The acquisition of multimodal functional data, wherein functional data from multiple modalities are concurrently recorded for a single subject, has emerged as a promising strategy for constructing more accurate gene regulatory networks (GRNs). While ordinary differential equation (ODE) methods have been extensively utilized for modeling GRNs, the existing methods are primarily tailored for single-modal data. In this paper, we introduce a multilinear ODE (ML-ODE) framework that integrates ODE-based dynamic modeling with multilinear operator mappings, presenting a versatile and potent approach for modeling GRNs using multimodal functional data. For each modality, we furnish a basis, within which the data and operators are represented, thereby transforming the problem into an algebraic optimization task that facilitates the inference of the GRNs. Regarding the inverse problem of deducing the structure of an ODE system from observed functional data, we formally define the concept of inferability for ODE system and demonstrate that the proposed ML-ODE is inferable under certain reasonable conditions. Ultimately, the model’s properties are validated through simulations, and we apply the ML-ODE framework to construct a GRN for real multimodal functional data derived from hematopoietic stem cells, showcasing that the resultant network is biologically significant, as corroborated by pertinent literature. *(abstract via OpenAlex)*
JASA High-Dimensional · 发表于 2026-08-27,收录于 2026-07-24
Not available
摘要
When applying multivariate extreme value statistics to analyze tail risk in compound events defined by a multivariate random vector, one often assumes that all dimensions share the same extreme value index. While such an assumption can be tested using a Wald-type test, the performance of such a test deteriorates as the dimensionality increases.This paper introduces novel tests for comparing extreme value indices in high-dimensional settings, under both weak and general cross-sectional tail dependence. We establish the asymptotic behavior of the proposed tests. The proposed tests significantly outperform existing methods in high-dimensional scenarios in simulations. We demonstrate real-life applications of the proposed tests for two datasets previously assumed to have identical extreme value indices across all dimensions. *(abstract via OpenAlex)*
JASA Bayesian Methods Clinical Trials · 发表于 2026-08-27
Luke Hagar, Shirin Golchi, Marina B. Klein
摘要
Group sequential designs drive innovation in clinical, industrial, and corporate settings. Early stopping for failure in sequential designs conserves experimental resources, whereas early stopping for success accelerates access to improved interventions. Bayesian decision procedures provide a formal and intuitive framework for early stopping using posterior and posterior predictive probabilities. Design parameters including decision thresholds and sample sizes are chosen to control the error probabilities associated with the sequential decision process. These choices are routinely made based on estimating the sampling distribution of posterior summaries via intensive Monte Carlo simulations for each sample size and design scenario considered. In this paper, we propose an efficient method to calibrate decision thresholds to pre-specified alpha- and beta-spending functions and determine minimum sample sizes for Bayesian group sequential designs. We prove theoretical results that enable posterior and posterior predictive probabilities to be modeled as a function of the sample size. Using these functions, we assess error probabilities at a range of sample sizes given simulations conducted at only two sample sizes. The effectiveness of our methodology is highlighted using several substantive examples. *(abstract via OpenAlex)*
JASA Latent Variables & Mixtures · 发表于 2026-08-27
Chenyang Wang, Yun Yang
摘要
This work introduces a new method for selecting the number of components in finite mixture models (FMMs) using variational Bayes, inspired by the large-sample properties of the Evidence Lower Bound (ELBO) derived from mean-field (MF) variational approximation. Specifically, we establish matching upper and lower bounds for the ELBO without assuming conjugate priors, suggesting the consistency of model selection for FMMs based on maximizing the ELBO. As a by-product, we show that the MF approximation inherits the stable behavior of the posterior distribution, which benefits from model singularity and tends to eliminate the extra components under model over-specification. This stable behavior also leads to the n−1/2 convergence rate for parameter estimation, up to a logarithmic factor, under model over-specification. Empirical experiments are conducted to validate our theoretical findings and compare with other advanced methods for selecting the number of components in FMMs. *(abstract via OpenAlex)*
JASA Causal Inference · 发表于 2026-08-27,收录于 2026-07-24
Not available
摘要
Sensitivity analysis is important to assess the impact of unmeasured confounding in causal inference from observational studies. The marginal sensitivity model (MSM) provides a useful approach in quantifying the influence of unmeasured confounders on treatment assignment and leading to tractable sharp bounds of common causal parameters. In this paper, to tighten MSM sharp bounds, we propose the enhanced MSM (eMSM) by incorporating another sensitivity constraint which quantifies the influence of unmeasured confounders on outcomes. We derive sharp population bounds of expected potential outcomes under eMSM, which are always narrower than the MSM sharp bounds in a simple and interpretable way. We further discuss desirable specifications of sensitivity parameters related to the outcome sensitivity constraint, and obtain both doubly robust point estimation and confidence intervals for the eMSM population bounds. The effectiveness of eMSM is also demonstrated numerically through two real-data applications. Our development represents for the first time a satisfactory extension of MSM to exploit both treatment and outcome sensitivity constraints on unmeasured confounding. *(abstract via PubMed)*